InvestorsHub Logo

Looking For Loot

04/02/08 4:52 PM

#1790 RE: gbwsf #1789

This news of FDA approval is great but the pps sucks. Everyone knows that the company is diluting shares right now and I think that's why we didn't see the volume today that we should have.

I've been an investor since September of 2006 and have been patiently waiting for FDA approval and this is what happens.

Hell when I first bought this stock there was four times more volume when they announced the prototype was completed and the price shot up to .32. Then we finally get FDA approval, even though partial approval still a major milestone for the advancement of the company and the Dominion and the pps goes up .0075. I mean come on not even a gain of a penny WTF.

I'm sure that Dean, Mike and everyone at Imaging3 are pissed off right now about the pps.

Just blowing off some steam. Congrats Dean maybe people will get a clue of what this company has to offer.

choctaw

04/02/08 4:53 PM

#1791 RE: gbwsf #1789

Could be that folks are not familiar with this type of approval: as opposed to full FDA approval. If this is the case, IMGG may want to clarify( PR, etc). GLTA

AOK11

04/03/08 12:20 AM

#1793 RE: gbwsf #1789

It looks like there may be more waiting involved. Unfortunately our 501(k) was one of the rare cases that require an IDE prior to being approved for the market. But at least we may be seeing some new images soon.

Investigational Device Exemption (IDE) - An IDE allows the investigational device to be used in a clinical study to collect safety and effectiveness data
required to support a Premarket Approval (PMA) application and in some rare situations a Premarket Notification (510(k)) submission. Only a small percentage of 510(k)s require clinical data to support a marketing clearance by the Food and Drug Administration (FDA). An IDE limits the distribution of an investigational device only to the sites identified in the IDE application. In addition to FDA requirements, clinical studies of devices are also monitored by Institutional Review Boards (IRB) located at hospitals or other facilities where the clinical studies are conducted. An IRB, is composed of medical experts and lay persons.